Glaucoma drainage devices: State of the art

Expert Review of Medical Devices

Volumn 3, Issue 4, 2006, Pages 509-521

  Ayyala, Ramesh S ^a   Duarte, Jessica Laursen ^a   Sahiner, Nurettin ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

Biomaterial; Fibrosis; Glaucoma drainage devices

Indexed keywords

DIMETICONE; FLUOROURACIL; MACROGOL; MITOMYCIN C; POLITEF; POLYACRYLIC ACID; POLYCARBONATE; POLYETHYLENE; POLYETHYLENE TEREPHTHALATE; POLYPROPYLENE; POLYURETHAN; SILICONE;

ANTERIOR EYE CHAMBER; AQUEOUS HUMOR FLOW; BIOCOMPATIBILITY; CONJUNCTIVA; EQUIPMENT DESIGN; FREQUENCY ANALYSIS; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; HISTORY OF MEDICINE; HUMAN; INTRAOCULAR PRESSURE; NANOTECHNOLOGY; POSTOPERATIVE COMPLICATION; REVIEW; SURGICAL ANATOMY; SURGICAL TECHNIQUE; TRABECULECTOMY; TREATMENT FAILURE; TREATMENT INDICATION;

BIOCOMPATIBLE MATERIALS; EQUIPMENT DESIGN; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANTS; HUMANS; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 33746646723     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.3.4.509     Document Type: Review

References (127)

1. Rollet M. Le drainage au irin de la chambre anterieure contre l'hypertonie et al douleur. Rev. Gen. Ophthalmol. 25, 481 (1906).
2. Zorab A. The reduction of tension in chronic glaucoma. Ophthalmoscope 10, 258 (1912).
3. Stefansson J. An operation for glaucoma. Am. J. Ophthalmol. 8, 681-692 (1925).
4. Muldoon WE, Ripple PH, Wilder HC. Platinum implant in glaucoma surgery. Arch. Ophthalmol. 45, 666 (1951).
5. Tronsco MU. Use of tantalum implants for inducing a permanent hypotony in rabbit eyes. Am. J. Ophthalmol. 32, 499-508 (1949).
6. Bock RH. Subconjunctival drainage of the anterior chamber by a glass seton. Am. J. Ophthalmol. 33, 929 (1950).
7. Epstein E. Fibrosis response to aqueous. Its relationship to glaucoma. Br. J. Opthalmol. 43, 641-647 (1959).
8. Molteno ACB. New implant for draining in glaucoma. Br. J. Ophthalmol. 53, 609 (1969).
9. Molteno AC, Straughan JL, Ancker E. Long tube implants in the management of glaucoma. S. Afr. Med. J. 50, 1062-1066 (1976).
10. Krupin T. Podas SM, Becker B, Newkirk JB. Valve implants in filtering surgery. Am. J. Ophthalmol. 81, 232-235 (1976).
11. Coleman AL, Hill R, Wilson MR et al. Initial clinical experience with the Ahmed Glaucoma Valve implant. Am. J. Ophthalmol. 120, 23-31 (1995).
12. Ayyala RS, Zurakowski D, Smith JA et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology 105, 1968-1976 (1998).
13. Huang MC, Netland PA, Coleman AL et al. Intermediate-term clinical experience with the Ahmed Glaucoma Valve implant. Am. J. Ophthalmol. 127, 27-33 (1999).
14. Topouzis F. Coleman AL, Choplin N et al. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am. J. Ophthalmol. 128, 198-204 (1999).
15. Molteno ACB. The optimal design of drainage implants for glaucoma. Trans. Ophthalmol. Soc. NZ 33, 29-41 (1981).
16. Minckler DS, Shammas A, Wilcox M, Ogden TE. Experimental studies of aqueous filtration using the Molteno implant. Trans. Am. Ophthalmol. Soc. 85, 368-392 (1987).
17. Heuer DK, Lloyd MA, Abrams DA et al. Which is better? One or two: a randomized clinical trial of single-plate versus double-plate molteno implantation for glaucomas in aphakia and pseudophakia. Ophthalmology 99, 1512-1519 (1992).
18. 2 Baerveldt implant: longer term results: is bigger better? Ophthalmology 106, 2312-2318 (1999).
19. Smith MF, Sherwood MB, McGorray SP. Comparison of the double-plate Molteno drainage implant with the Schocket procedure. Arch. Ophthalmol. 110, 1246-1250 (1992).
20. 2 glaucoma implant and associated extraocular muscle imbalance. Ophthalmology 100, 914-918 (1993).
21. 2 Baerveldt implant. Ophthalmology 101, 1456-1463 (1994).
22. Siegner SW, Netland PA, Urban RC et al. Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology 102, 1298-1307 (1995).
23. Molteno ACB, Polkinghorne PJ, Bowbyes JA. The Vicryl tie technique for inserting a drainage implant in the treatment of secondary glaucoma. Aust. N Z J. Ophthalmol. 14, 343-354 (1986).
24. Sherwood MB, Smith MF. Prevention of early hypotony associated with Molteno implants by a new occluding stent technique. Ophthalmology 100, 85-90 (1993).
25. Egbert PR, Lieberman MF. Internal suture occlusion of the Molteno glaucoma implant for the prevention of postoperative hypotony. Ophthalmic Surg. 20, 53-56 (1989).
26. Price FW Jr, Whitson WE. Polypropylene ligatures as a means of controlling intraocular pressure with Molteno implants. Ophthalmic Surg. 20, 781-783 (1989).
27. Latina MA. Single-stage Molteno implant with combination internal occlusion and external ligature. Ophthalmic Surg. 21, 444-446 (1990).
28. Petitti DB. Advanced Issues in Meta-Analysis, Decision Analysis, and Cost-Effective Analysis: Methods for Quantitative Synthesis in Medicine. Oxford University Press, NY, USA, 75-93 (2000).
29. Brown RD, Cairns JE. Experience with the Molteno long tube implant. Trans. Opthalmol. Soc. UK 103, 297-312 (1983).
30. Freedman J. The use of the single-stage Molteno long-tube seton in treating resistant cases of glaucoma. Ophthalmol. Surg. 16, 480-483 (1985).
31. Goldberg I. Management of uncontrolled glaucoma with the Molteno system. Aust. N Z J. Ophthalmol. 15, 97-107 (1987).
32. Ward WJ, Cooper RL. Molteno tube implants: long-term results. Aust. N Z J. Ophthalmol. 15, 109-112 (1987).
33. Downes RN, Flanagan DW, Jordan K et al. The Molteno implant in intractable glaucoma. Eye 2, 250-259 (1988).
34. Hoare Nairne JE, Sherwood D, Jacob JS et al. Single-stage insertion of the Molteno tube for glaucoma and modifications to reduce postoperative hypotony. Br. J. Ophthalmol. 72, 846-851 (1988).
35. Minckler DS, Heuer DK, Hasty B et al. Clinical experience with the single-stage Molteno implant in complicated glaucomas. Ophthalmology 95, 1181-1188 (1988).
36. Traverso CE, Tomey KF, al-Kaff A. The long-tube single plate Molteno implant for the treatment of recalcitrant glaucoma. Int. Ophthalmol. 13, 159-162 (1989).
37. Airaksinen PJ, Aisala P, Tuulonen A. Molteno implant surgery in uncontrolled glaucoma. Acta Ophthalmol. 68, 690-694 (1990).
38. Melamed S, Cahane M, Gutman I et al. Postoperative complications after Molteno implant surgery. Am. J. Ophthalmol. 111, 319-322 (1991).
39. El-Sayyad F, El-Maghraby A, Helal M et al. The use of releasable sutures in Molteno glaucoma implant procedures to reduce postoperative hypotony. Ophthalmic Surg. 22, 82-84 (1991).
40. Freedman J, Rubin B. Molteno implants as a treatment for refractory glaucoma in black patients. Arch. Ophthalmol. 109, 1417-1420 (1991).
41. Lotufo DG. Postoperative complications and visual loss following Molteno implantation. Ophthalmic Surg. 22, 650-656 (1991).
42. Freedman J. Clinical experience with the Molteno dual-chamber single-plate implant. Ophthalmic Surg. 23, 238-241 (1992).
43. Lloyd MA, Sedlak T, Heuer DK et al. Clinical experience with the single-plate Molteno implant in complicated glaucomas. Update of a pilot study. Ophthalmology 99, 679-687 (1992).
44. Wilson RP, Cantor L, Katx LJ et al. Aqueous shunts: Molteno versus Schocket. Ophthalmology 99, 672-676 (1992).
45. Mermoud A, Salmon JF, Straker C et al. Use of the single-plate Molteno implant in refractory glaucoma. Ophthalmologica 205, 113-120 (1992).
46. Bluestein EC, Stewart WC. Trabeculectomy with 5-fluorouracil vs single-plate Molteno implantation. Ophthalmic Surg. 24, 669-673 (1993).
47. Neelakantan A, Rao BS, Vijaya L et al. Single-plate Molteno implants in complicated glaucomas: results, survival rates, and complications. Indian J. Ophthalmol. 42, 193-197 (1994).
48. Stewart WC, Connor AB, Pitts RA. Prognostic factors and postoperative course following single-plate Molteno implantation. Doc. Ophthalmol. 86, 409-417 (1994).
49. Price FW Jr, Wellemeyer M. Long-term results of Molteno implants. Ophthalmic Surg. 26, 130-135 (1995).
50. Verdonck C, Van de Velde T, Zeyen T. Clinical experience with the single-plate Molteno drainage implant. Bull. Soc. Belge Ophthalmol. 225, 27-32 (1995).
51. Mills RP, Reynolds A, Emond MJ et al. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology 103, 299-305 (1996).
52. Broadway DC, Iester M, Schulzer M, Douglas GR. Survival analysis for success of Molteno tube implants. Br. J. Ophthalmol. 85, 689-695 (2001).
53. Molteno AV, Bevin TH, Herbison P, Houliston MJ. Otago Glaucoma Surgery Outcome Study. Ophthalmology 108, 2193-2200 (2001).
54. Aung T, Seah SK. Glaucoma drainage implants in Asian eyes. Ophthalmology 105, 2117-2122 (1998).
55. Kee C. Prevention of early postoperative hypotony by partial ligation of silicone tube in Ahmed glaucoma valve implantation. J. Glaucoma 10, 466-469 (2001).
56. Wilson MR, Mendis U, Smith SD, Paliwal A. Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Am. J. Ophthalmol. 130, 267-273 (2000).
57. Kook MS, Yoon J, Kim J, Lee MS. Clinical results of Ahmed glaucoma valve implantation in refractory glaucoma with adjunctive mitomycin-C. Ophthalmic Surg. Lasers 31, 100-106 (2000).
58. Lai JS, Poon AS, Chua Jk et al. Efficacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucoma. Br. J. Ophthalmol. 84, 718-721 (2000).
59. Ayyala RS, Zurakowski D, Monshizadeh R et al. Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg. Lasers 33, 94-101 (2002).
60. Lloyd MA, Baerveldt G, Heuer DK et al. Initial clinical experience with the Baerveldt implant in complicated glaucomas. Ophthalmology 101, 640-650 (1994).
61. Smith MF, Doyle JW, Sherwood MB. Comparison of the Baerveldt glaucoma implant with the double-plated Molteno drainage implant. Arch. Ophthalmol. 113, 444-447 (1995).
62. Hodkin MJ, Goldblatt WS, Burgoyne CF et al. Early clinical experience with the Baerveldt implant in complicated glaucomas. Am. J. Ophthalmol. 120, 32-40 (1995).
63. Nguyen QH, Budenz DL, Parrish RK II. Complications of Baerveldt glaucoma drainage implants. Arch. Ophthalmol. 116, 571-575 (1998).
64. 2 Baerveldt glaucoma implants. Ophthalmology 108, 621-626 (2001).
65. The Krupin eye valve filtering surgery study group: Krupin eye valve with disk for filtration surgery. Ophthalmology 101, 651-658 (1994).
66. Fellenbaum PS, Almeida AR, Minckler DS et al. Krupin disk implantation for complicated glaucomas. Ophthalmology 101, 1178-1182 (1994).
67. Fleiss JL. The Comparison of Proportions from Several Independent Samples in Statistical Methods for Rates and Proportions. John Wiley & Sons, NY, USA, 138-159 (1981).
68. Piantadosi S. Overviews/Meta-Analyses in Clinical Trials: A Methodologic Perspective. John Wiley & Sons, NY, USA, 419-431 (1997).
69. Hill RA, Pirouzian A, Liaw L. Pathophysiology of and prophylaxis against late Ahmed glaucoma valve oclusion. Am. J. Ophthalmol. 129, 608-612 (2000).
70. Hong CH, Arosemena A, Zurakowski D, Ayyala RS. Glaucoma drainage devices. A systematic literature review and current controversies. Surv. Ophthalmol. 50, 48-60 (2005).
71. Syed HM, Law SK, Nam SH, Li G, Caprioli J, Coleman A. Baerveldt-350 implant versus Ahmed valve for refractory glaucoma: a case-controlled comparison. J. Glaucoma 13, 38-45 (2004).
72. Tsai JC, Johnson CC, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison of outcome. Ophthalmology 110, 1814-1821 (2003).
73. Minckler DS, Vedula SS, Li TJ, Mathew MC, Ayyala RS, Francis BA. Aqueous shunts for glaucoma. Cochrane Database Syst. Rev. 2, CD004918 (2006).
74. Ayyala RS, Harman LE, Stevens SX, Haller E. Comparison of different biomaterials for the glaucoma drainage devices. Arch. Ophthalmol. 117, 233-236 (1999).
75. Ayyala RS, Margo CE, Michelini-Norris MB et al. Comparison of different biomaterials for the glaucoma drainage devices: part 2. Arch. Ophthalmol. 118, 1081-1084 (2000).
76. Molteno ACB, Dempster AG. Methods of controlling bleb fibrosis around draining implants. In: Glaucoma: Proceedings of Fourth International Symposium of the North Eye Institute, Manchester UK. Mills KB (Ed.). Pergamon Press Inc, NY, USA, 192-211 (1988).
77. Teng CC, Chi HH, Katzin HM. Histology and mechanism of filtering operations. Am. J. Ophthalmol. 47, 16-34 (1959).
78. Schocket SS. Investigations of the reasons for success and failure in the anterior shunt-to-the-encircling-band procedure in the treatment of refractory glaucoma. Trans. Am. Ophthalmol. Soc. 84, 743-798 (1986).
79. Wilcox MJ, Barad JP, Wilcox CC, Peebles EL, Minckler DS. Performance of a new, low-volume, high-surface area aqueous shunt in normal rabbit eyes. J. Glaucoma 9(1), 74-82 (2000).
80. Molteno ACB, Straughan JL, Ancker E. Control of bleb fibrosis after glaucoma surgery by anti-inflammatory agents. S. Afr. Med. J. 50, 881-885 (1976).
81. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J. Exp. Med. 178, 2147-2156 (1993).
82. Law KS, Nguyen A, Coleman AL, Caprioli J. Comparison of safety and efficacy between silicone and polypropylene Ahmed glaucoma valves in refractory glaucoma. Ophthalmology 112, 1514-1520 (2005).
83. Hinkle DH, Zurakowski D, Ayyala RS. A comparison of the polypropylene plate Ahmed™ glaucoma valve to the silicone plate Ahmed™ glaucoma flexible valve. Association for Research in Vision and Ophthalmology Abstract, FL, USA, May (2005).
84. Jacob-Labarre JT, McKinnon SJ, Tanji T. Biocompatibilty response to modified Baerveldt glaucoma drains. Invest. Ophthalmol. Vis. Sri. 37(Suppl.), 1164 (1996).
85. Ayyala RS, Parma SE, Karcioglu ZA. Optic nerve changes following posterior insertion of glaucoma drainage device in a rabbit model. J. Glaucoma 13(2), 145-148 (2004).
86. Leen MM, Witkop GS, George DP. Anatomic considerations in the implantation of the Ahmed glaucoma valve. Arch. Ophthalmol. 114, 223-224 (1996).
87. Ayyala RS, Layden WE, Slonim CB, Margo CE. Anatomic and histopathologic findings following a failed Ahmed glaucoma valve device. Ophthalmic Surg. Lasers 32, 248-249 (2001).
88. Kahook MY, Noecker RJ, Pantcheva MB, Schuman JS. Location of glaucoma drainage devices relative to the optic nerve. Br. J. Ophthalmol. doi: 10.1136/bjo.2006.091272 (2006).
89. Perkins TW, Cardakli UF, Eisele JR et al. Adjunctive mitomycin-C in Molteno implant surgery. Ophthalmology 102, 91-97 (1995).
90. Perkins TW, Gangnon R, Ladd W et al. Molteno implant with mitomycin-C: intermediate results. J. Glaucoma 7, 86-92 (1998).
91. Susanna R, Nicolela MT, Takahashi WY. Mitomycin-C as adjunctive therapy with glaucoma implant surgery. Ophthalmic Surg. 25, 458-462 (1994).
92. Cantor L, Burgoyne J, Sanders S et al. The effect of mitomycin-C on Molteno implant surgery: 1-year randomized masked study. J. Glaucoma 7, 240-246 (1998).
93. Lee D, Shih DH, Birt CM et al. The effect of adjunctive mitomycin C in Molteno implant surgery. Ophthalmology 104, 2126-2135 (1997).
94. Rapuano CJ, Schmidt CM, Cohen EJ et al. Results of alloplastic tube shunt procedures before, during, or after penetrating keratoplasty. Cornea 14, 26-32 (1995).
95. Beebe W, Starita R, Fellman RL, Lynn JR, Gelender H. The use of Molteno implant and anterior chamber tube shunt to encircling band for the treatment of glaucoma in keratoplasty patients. Ophthalmology 97, 1414-1422 (1990).
96. Ayyala RS, Pieroth L, Vinals AF et al. Comparison of mitomycin-C trabeculectomy, glaucoma drainage devices and laser Nd:YAG cyclophotocoagulation in the management of intractable glaucoma following keratoplasty. Ophthalmology 105, 1550-1556 (1998).
97. Kirkness CM. Penetrating keratoplasty, glaucoma and silicone drainage tubing. Dev. Ophthalmol. 14, 161-165 (1987).
98. Bigar F, Witmer R. Corneal endothelial changes in primary acute angle-closure glaucoma. Ophthalmology 89, 596-599 (1982).
99. Svedberg B. Effects of artificial intraocular pressure elevation on the corneal endothelium in the vervet monkey. Acta Ophthalmol. 53, 839-855 (1975).
100. McDermott ML, Swendris RP, Shin DH et al. Corneal endothelial cell counts after Molteno implantation. Am. J. Ophthalmol. 115, 93-96 (1993).
101. Lloyd MA, Heuer DK, Baerveldt DC. Combined Molteno implantation and parsplana vitrectomy for neovascular glaucomas. Ophthalmology 981, 1401-1405 (1991).
102. Varma R, Heuer DK, Lundy DC. Parsplana Baerveldt tube insertion with vitrectomy in glaucomas associated with pseudophakia and aphakia. Am. J. Ophthalmol. 119, 401-407 (1995).
103. Sidoti PA, Mosny AY, Ritterband DC, Seedor JA. Parsplana tube insertion of glaucoma drainage implants and penetrating keratoplasty in patients with coexisting glaucoma and corneal diseases. Ophthalmology 108, 1050-1058 (2001).
104. Joos KM, Lavina TA, Agarwal A. Posterior repositioning of glaucoma implants for anterior segment complications. Ophthalmology 108, 279-284 (2001).
105. Nyska A, Glovinsky Y, Belkin M, Epstein Y. Biocompatibility of the Ex-PRESS miniature glaucoma drainage implant. J. Glaucoma 12(3), 275-280 (2003).
106. Wamsley S, Moster MR, Rai S, Alvim HS, Fontanarosa J. Results of the use of the Ex-PRESS miniature glaucoma implant in technically challenging, advanced glaucoma cases: a clinical pilot study. Am. J. Ophthalmol. 138(6), 1049-1051 (2004).
107. Stewart RM, Diamond JG, Ashmore ED, Ayyala RS. Complications following express glaucoma shunt implantation. Am. J. Ophthalmol. 140(2), 340-341 (2005).
108. Dahan E, Carmichael TR. Implantation of a miniature glaucoma device under a scleral flap. J. Glaucoma 14(2), 98-102 (2005).
109. Blake DA, Clinton AD, Galler KE et al. Inhibition of cell proliferation by mitomycin C incorporated into P(HEMA) hydrogels: mitomycin C in a P(HEMA) matrix - a novel slow release drug delivery system to decrease encapsulation/fibrosis following glaucoma drainage device implantation: an in vitro test of efficacy. J. Glaucoma (In press).
110. Vadgama P. Surface biocompatibility. Annual Reports on the Progress of Chemistry, Section C: Physical Chemistry 101, 14-52 (2005).
111. Rosiak JM, Yoshii F. Hydrogels and their medical applications. Nucl. Instrum. Methods Phys. Res. B 151, 56-64 (1999).
112. Pompe W, Worch H, Epple M et al. Functionally graded materials for biomedical applications. Mater. Sci. Eng. A 362(1-2), 40-60 (2003).
113. Kholodovych V, Smith RJ, Knight D, Abramson S, Kohn J, Wels JW. Accurate prediction of celluar response using QSPR: a feasibility test of rational design of polymeric biomaterials. Polymer 4, 7367-7379 (2004).
114. Puskas JE, Chen Y. Biomedical application of commercial polymers and novel polyisobutylene-based thermoplastic elastomers for soft tissue replacement. Biomacromolecules 5(4), 1141-1154.
115. Tang L, Hu W. Molecular determinants of biocompatibility. Expert Rev. Med. Devices 2(4), 493-500 (2005).
116. Shintani H. Modification of polymer surfaces of medical devices to prevent infections. Biocontrol Sci. 10(1&2), 3-11 (2005).
117. Wang A, Cao T, Tang H et al. Immobilization of polysaccharides on a fluorinated silicone surface. Colloids Surf. B: Biointerfaces 47, 57-63 (2006).
118. Kaci M, Touati N, Setnescu R, Zaharescu T, Setnescu T, Jipa S. Grafting of hindered amine stabilizer in poly(propylene) films under γ-irradiation. Macromolecular Mater. Eng. 290(8), 802-808 (2005).
119. Svorcik V, Hnatowicz V, Stopka P et al. Amino acids grafting of Ar+ ions modified PE. Radiation Physics and Chemistry 60(1-2), 89-93 (2001).
120. Tan BW, Zhang Y. Surface modification of gold and quantum dot nanoparticles with chitosan for bioapplicatons. J. Biomed. Mater. Res. Part A 75A(1), 56-62 (2005).
121. Zahr SA, Villiers de M, Pishko VM. Encapsulation of drug nanoparticles in self-assembled macromolecular nanoshells. Langmuir 21, 403-410 (2005).
122. Chung AH, Kato K, Ohhashi S, Nagamune T. Casual cell surface remodeling using biocompatible lipid poly(ethylene glycol)(n): development of stealth cells and monitoring of cell membrane behavior in serum supplemented conditions J. Biomed. Mater. Res. Part A 70A(2), 179-185 (2004).
123. Moghimi SM. Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers. Biochim. Biophys Acta 1590, 131-139 (2002).
124. Osada Y, Gong JP. Soft and wet materials: polymer gels. Adv. Mater. 10(11), 827-837 (1998).
125. Okano T. Biorelated Polymers and Gels: Controlled Release and Applications in Biomedical Engineering. Academic Press, CA, USA, 1-135 (1998).
126. Peppas AN, Buresa P, Leobandunga W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50, 27-46 (2000).
127. Molteno ACB, Fucik M, Dempster AG, Bevin TH. Otago glaucoma surgery outcome study: factors controlling capsule fibrosis around Molteno implants with histological correlation. Ophthalmology 110, 2198-2206 (2003).